Evidence map›Paper›PMID 40770533›Full record

ArticleTherapeutic innovation & regulatory science2025

Advancing Global Harmonization: Implementing Global Dose Form Attributes for Medicinal Products Identification.

Emelie Ahnfelt, Olof Lagerlund, Jenny Klint, Malin Fladvad, Christopher Jarvis, Ta-Jen Chen, Panagiotis Telonis, Ronald Fitzmartin

Abstract read
In one paragraph

Article in Therapeutic innovation & regulatory science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emelie AhnfeltUppsala Monitoring Centre, Uppsala, Sweden. emelie.ahnfelt@who-umc.org.
Olof LagerlundUppsala Monitoring Centre, Uppsala, Sweden.
Jenny KlintUppsala Monitoring Centre, Uppsala, Sweden.
Malin FladvadUppsala Monitoring Centre, Uppsala, Sweden.
Christopher JarvisEuropean Directorate for the Quality of Medicines and HealthCare, Strasbourg, France.
Ta-Jen ChenUnited States Food and Drug Administration, Silver Spring, USA.
Panagiotis TelonisEuropean Medicines Agency, Amsterdam, Netherlands.
Ronald FitzmartinUnited States Food and Drug Administration, Silver Spring, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global pharmaceutical market includes a wide range of medicinal products, which makes it difficult to achieve consistent identification and classification across different regions. To address this, the International Organization for Standardization (ISO) developed five standards that together create a framework for the Identification of Medicinal Products (IDMP). Implementing the ISO IDMP standards globally necessitates collaboration to ensure consistent data. As part of these efforts, investigations were conducted to explore the feasibility of introducing global dose form attributes, which aim to standardize dose forms worldwide. These characteristics, defined by the European Directorate for the Quality of Medicines (EDQM), include the administrable basic dose form, administration method, intended site, and release characteristics. The global dose form attributes were successfully applied to data from nine countries, representing six dose form terminologies or lists, and were successfully assigned to over 99% of medicinal products. The process of assigning global dose form attributes was improved by mapping local dose form terminologies to global dose form attributes. The results from these studies were used to develop business rules for assigning the global dose form attributes.

Indexed as

Dosage FormsHumansInternational CooperationPharmaceutical PreparationsDosage FormsPharmaceutical PreparationsDose form terminologiesGlobal Medicinal HarmonizationIdentification of Medicinal Products (IDMP)International Organization for Standardization (ISO)PharmacovigilanceStandardize dose forms

Identifiers

PMID40770533
PMCPMC12579665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.